Abstract
Psoriatic arthritis (PsA) is a heterogeneous, immune-mediated disease that significantly impacts quality of life, functional capacity, and healthcare systems. Over the past two decades, treatment options have expanded from conventional therapies to biologic and targeted synthetic DMARDs, enabling more effective disease control. However, many patients still fail to achieve remission or low disease activity (LDA), reflecting challenges in selecting the right treatment at the right time for the right patient. This perspective introduces a conceptual framework for PsA management using the metaphor of a journey, emphasizing three key dimensions: patient heterogeneity ("vehicle"), therapeutic options ("fuel"), and the timing of the intervention ("road"). Aligning these factors can optimize care, reduce disease burden, and improve long-term outcomes.